Literature DB >> 10461717

Iron accumulation in the substantia nigra in rats visualized by ultrasound.

D Berg1, C Grote, W D Rausch, M Mäurer, W Wesemann, P Riederer, G Becker.   

Abstract

In recent studies, we have found a marked increase in substantia nigra (SN) echogenicity in patients with Parkinson's disease (PD) using transcranial ultrasound. Because a substantial body of evidence has accumulated indicating a selective elevation of iron in the SN from patients with PD, we set out to test the hypothesis that trace metals like iron could lead to the observed increase of SN echogenicity in PD. Rat brains were scanned after stereotactic injection of iron in different concentrations into the SN and after injecting ferritin, zinc and 6-OHDA alone, and after the addition of desferrioxamine. The amount of iron in the SN was measured spectroscopically. For iron, and partly for 6-OHDA, in different concentrations, a dose-dependent increase of SN echogenicity could be visualized, corresponding to an increase of iron measured by spectroscopy. No increase of echogenicity was visualized after the injection of ferritin and the addition of desferrioxamine to 6-OHDA, though an increase of iron was measured by spectroscopy. Therefore, we conclude that iron not bound to these proteins may lead to an increase of echogenicity of the SN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461717     DOI: 10.1016/s0301-5629(99)00046-0

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  36 in total

Review 1.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

2.  In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.

Authors:  D Berg
Journal:  J Neural Transm (Vienna)       Date:  2006-05-18       Impact factor: 3.575

3.  Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

Authors:  Chung-Fen Tsai; Ruey-Meei Wu; Yu-Weng Huang; Li-Ling Chen; Ping-Keung Yip; Jiann-Shing Jeng
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein.

Authors:  Uwe Walter; Rike Witt; Alexander Wolters; Matthias Wittstock; Reiner Benecke
Journal:  J Neural Transm (Vienna)       Date:  2011-05-31       Impact factor: 3.575

Review 5.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 6.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

7.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

8.  Microglia activation is related to substantia nigra echogenicity.

Authors:  D Berg; J Godau; P Riederer; M Gerlach; T Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

Review 9.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

10.  Transcranial sonography in pantothenate kinase-associated neurodegeneration.

Authors:  Vladimir S Kostić; Marina Svetel; Milija Mijajlović; Aleksandra Pavlović; Milica Ječmenica-Lukić; Duško Kozić; Dušan Kozić
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.